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The innate immune system is a critical component of
host defense against invading microbial pathogens. It is
responsible for mounting proper inflammatory and repair
responses that contribute to the elimination of the invading
pathogen and for instructing the adaptive immune system to
develop a prolonged immunity against microbial pathogens.
This is accomplished through the regulation of transcrip-
tional and posttranslational programs that culminate in the
production of proinflammatory cytokines and chemokines,
the induction of type I and II interferon responses and
autophagy responses, and the induction of programmed
cell death modes that eliminate infected host cells and
expose intracellular pathogens to surveillance by the immune
system. This issue includes eight published papers which are
discussing the following issues.
In the article “The EGF receptor and HER2 participate
in TNF-α-dependent MAPK activation and IL-8 secretion in
intestinal epithelial cells,” by H. B. Jijon et al., the authors
provide evidence that TNF activates one ormoremetallopro-
teinases leading to the release of TGF-α in intestinal epithelial
cells.
In the article “Innate immune cells in liver inflammation,”
by E. Liaskou et al., the authors discuss the innate immune
cells that take part in human liver inflammation, and their
roles in both resolution of inflammation and tissue repair.
In the article “Optimizing dendritic cell-based immun-
otherapy: Tackling the complexity of diﬀerent arms of the
immune system,” by I. Brussel et al., the authors explore
the molecular and cellular mechanisms underlying adequate
immune responses and focus on most favourable DC culture
regimens and activation stimuli in humans. Also, they
envisage that by combining each of the features outlined in
the current paper into a unified strategy, DC-based vaccines
may advance to a higher level of eﬀectiveness.
In the article “Danger signals activating the immune
response after trauma,” by S. Hirsiger et al., the authors focuse
on the role of the dual function DAMPs in the initiation of
the immune response after trauma.Moreover, they shed light
on recently discovered mechanisms of activation of innate
immunity by mitochondrial DAMPs released from disrupted
cells which bear bacterial molecular motifs similar to PAMPs
due to their endosymbiotic origin.
In the article “Guilty molecules, guilty minds? The con-
flicting roles of the innate immune response to traumatic brain
injury” by S. Hellewell and M. Morganti-Kossmann, the
authors discuss the positive, negative, and often conflicting
roles of the innate immune response to TBI in both an
experimental and clinical settings and highlights recent
advances in the search for therapeutic candidates for the
treatment of TBI.
In the article “Interplay between human cytomegalovirus
and intrinsic/innate host responses: A complex bidirectional
relationship” by G. Rossini., the authors review the viral
and cellular partners that mediate early host responses to
HCMV with regard to the interaction between structural
components of virions (viral glycoproteins) and cellular
receptors (attachment/entry receptors, toll-like receptors,
and other nucleic acid sensors) or intrinsic factors (PML,
hDaxx, Sp100, viperin, interferon inducible protein 16), the
reactions of innate immune cells (antigen presenting cells
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and natural killer cells), the numerous mechanisms of viral
immunoevasion, and the potential exploitation of events that
are associated with early phases of virus-host interplay as a
therapeutic strategy.
In the article “Lipopolysaccharides: From Erinyes to Char-
ites” by A. Foca` et al., the authors focuse on recent data
supporting a beneficial activity of both typical and atypical
endotoxins. Such novel perspective looks promising for the
development of new drugs for the prevention and therapy of
several human diseases.
In the article “Essential role of mast cells in the visceral
hyperalgesia induced by T. spiralis infection and stress in rats”
by C.-Q. Yang et al., the authors show that the visceral
hyperalgesia cannot be triggered by stress in MCs-deficient
rats, although both stress and infection play an important
role in visceral hyperalgesia in wild control rats.
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